Investors
For every euro invested, €5.19 in healthcare and societal costs has been saved. That figure has been measured across our portfolio since 2018. Three funds, 23 companies and one conviction: solving a real healthcare problem creates value for investors and for society at the same time.
Impact is our and your competitive advantage
Impact in healthcare investing is measurable. We prove it.
We measure what changes
Impact should be more than a promise. We use the LIFe Impact Framework to measure the societal value our companies create. Developed with Invest-NL, PGGM, Achmea IM, VGZ and CbusineZ, it provides a shared methodology for measuring impact in healthcare investments.
We apply it across our portfolio and publish the results. If we cannot substantiate a number, we do not claim it.
We apply it across our portfolio and publish the results. If we cannot substantiate a number, we do not claim it.
Our incentives are aligned
Impact is built into the economics of our fund. Our carried interest is linked to both financial performance and measurable impact, independently monitored throughout the life of the fund.
We succeed when our investors generate returns and healthcare gets better.
We succeed when our investors generate returns and healthcare gets better.
Digital health is all we do
We have invested exclusively in early-stage digital health since 2018. Three funds, 23 companies, one sector.
This focus enables us to recognize patterns: we understand the journey from clinical validation to adoption, reimbursement, and scale—allowing us to identify challenges before they become roadblocks.
This focus enables us to recognize patterns: we understand the journey from clinical validation to adoption, reimbursement, and scale—allowing us to identify challenges before they become roadblocks.
Impact drives returns
The most robust healthcare businesses solve problems that hold genuine economic value: increasing capacity, reducing costs, preventing unnecessary care, and improving treatment outcomes.
For us, impact and financial performance are not competing objectives. Impact is what gives a business its value, while evidence is what makes it scalable.
Proven track record since 2018: the green color does not align with our brand guidelines.
For us, impact and financial performance are not competing objectives. Impact is what gives a business its value, while evidence is what makes it scalable.
Proven track record since 2018: the green color does not align with our brand guidelines.
Proven track record since 2018
3
Active funds, €42M raised
€80M
Follow-on capital raised by our portfolio
85
Clinical studies completed and ongoing
23
Companies backed
5
Companies reimbursed by Dutch health insurers
2
Exits to date
